Chiasma (CHMA) Priced

Biotech developing oral therapies for orphan diseases only treated by injections.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.60 0.00 (0.0%)
First Day Return 25.0%
Return from IPO -90.0%
 
Chiasma IPO News more
  • .
IPO Data
IPO File Date 06/15/2015
Offer Price $16.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.4
Deal Size ($mm) 102
 
IPO Data
IPO Date 07/15/2015
Offer Price $16.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.4
Deal Size ($mm) $102
 
Underwriters
more
Business Overview
Biotech developing oral therapies for orphan diseases only treated by injections.
Biotech developing oral therapies for orphan diseases only treated by injections.
more
Company Data
Headquarters Newton, MA
Founded 2001
Employees 13
Website www.chiasmapharma.com
 

Performance vs. IPO Index (IPOUSA)